BusinessBellicum Announces Update on Clinical Hold of U.S. BPX-501 StudiesBy Nasdaq OMXFeb 23, 2018, 12:00 PM UTC
BusinessBellicum Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate UpdateBy Nasdaq OMXAug 8, 2017, 8:06 PM UTC
BusinessBellicum Reports Clinical Results of BPX-501 in Pediatric Leukemias at the 22nd Congress of the European Hematology AssociationBy Nasdaq OMXJun 23, 2017, 11:00 AM UTC
BusinessBellicum Announces Clinical Data on BPX-501 at Presidential Symposium of the 22nd Congress of the European Hematology AssociationBy Nasdaq OMXJun 23, 2017, 11:00 AM UTC
BusinessBellicum Pharmaceuticals Announces Closing of Public OfferingBy Nasdaq OMXMar 30, 2017, 11:00 AM UTC
BusinessBellicum to Report Fourth Quarter and Full Year 2016 Financial Results and Host Conference Call and Webcast on March 13, 2017By Nasdaq OMXMar 6, 2017, 12:00 PM UTC
